Cargando…

The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes

Detalles Bibliográficos
Autores principales:	Klein, Ronald, Horak, Kayla, Lee, Kristine E., Danforth, Lorraine, Cruickshanks, Karen J., Tsai, Michael Y., Gangnon, Ronald E., Klein, Barbara E.K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2017
Materias:	e-Letters: Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566284/ https://www.ncbi.nlm.nih.gov/pubmed/28630056 http://dx.doi.org/10.2337/dc17-0421

Ejemplares similares

Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease
por: Liu, Wenjun, et al.
Publicado: (2022)

Retracted: Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020)

sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Concentrations of N(6)-Carboxymethyllysine (CML), N(6)-Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients
por: Damasiewicz-Bodzek, Aleksandra, et al.
Publicado: (2022)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD
por: Gopal, Poornima, et al.
Publicado: (2014)

CML/RAGE signal induces calcification cascade in diabetes
por: Wang, Zhongqun, et al.
Publicado: (2016)

sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy
por: Arabi, Yaseen M, et al.
Publicado: (2011)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

Assessing Progress in Retinopathy Outcomes in Type 1 Diabetes: Comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy
por: LeCaire, Tamara J., et al.
Publicado: (2013)

DNA and sRAGE circulation in the early phase after polytrauma
por: Joly, P, et al.
Publicado: (2015)

The period effect in the prevalence of proliferative diabetic retinopathy, gross proteinuria, and peripheral neuropathy in type 1 diabetes: A longitudinal cohort study
por: Kiire, Christine A., et al.
Publicado: (2017)

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro
por: Miller, Suzanne, et al.
Publicado: (2016)

Soluble Receptor for Advanced Glycation End-Product (sRAGE)/Pentosidine Ratio: A Potential Risk Factor Determinant for Type 2 Diabetic Retinopathy
por: Ng, Zhi Xiang, et al.
Publicado: (2013)

Acute and Chronic Effects of Cigarette Smoking on sRAGE
por: Biswas, Subrata K.
Publicado: (2019)

Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia
por: Southern, Louise, et al.
Publicado: (2007)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer
por: Kim, Taehee, et al.
Publicado: (2023)

Plasma Levels of Free N(Ɛ)-Carboxymethyllysine (CML) after Different Oral Doses of CML in Rats and after the Intake of Different Breakfasts in Humans: Postprandial Plasma Level of sRAGE in Humans
por: Helou, Cynthia, et al.
Publicado: (2022)

Corrigendum: Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

SUN-LB131 Association of Receptor for Advanced Glycation End Product (RAGE) Gene Polymorphisms & Serum Levels of Soluble RAGE (sRAGE) With Metabolic Syndrome (MS) in Mexican Population
por: Gonzalez-Guerrero, Diana Elizabeth, et al.
Publicado: (2020)

sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells
por: Zhang, Fang, et al.
Publicado: (2017)

Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients
por: Jung, Eul Sik, et al.
Publicado: (2017)

The effects of low-dose Nepsilon-(carboxymethyl)lysine (CML) and Nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function
por: Zhu, Jinzhou, et al.
Publicado: (2012)

sRAGE in septic shock: a potential biomarker of mortality
por: Hamasaki, Mike Yoshio, et al.
Publicado: (2014)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2019)

The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes
por: Erusalimsky, Jorge D.
Publicado: (2021)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
por: Nowak, Agnieszka, et al.
Publicado: (2021)

Letter to the Editor, Reacting to: “APOE ε4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism”
por: Mooldijk, Sanne S, et al.
Publicado: (2020)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Schalkwijk, Casper G., et al.
Publicado: (2013)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Yamagishi, Sho-ichi
Publicado: (2013)

The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease
por: Chen, Der-Yuan, et al.
Publicado: (2015)

Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Dozio, Elena, et al.
Publicado: (2018)

Association of soluble receptor for advanced glycation end-products (sRAGE) serum on COVID-19 severity: A cross-sectional study
por: Saputra, Gusti Noor Ramadany, et al.
Publicado: (2022)

Reply to Biswas: Acute and Chronic Effects of Cigarette Smoking on sRAGE
por: Pouwels, Simon D., et al.
Publicado: (2019)

The ratio of AGE to sRAGE independently associated with albuminuria in hypertensive patients
por: Chiang, Kuang-Hsing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6bv28ikn5jpgpkal0gs4ueldlj